Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Program: Scientific Session
General Topic: Basic Science

Bullseye! What's the Target for T Cell-Targeted Therapies?

Sunday, October 26, 2025
9:00 AM – 10:00 AM Central Time

    Moderator(s)

  • MC

    Marcus Clark, MD

    University of Chicago
    Chicago, Illinois, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • Melanie Smith, MD, PhD

    Hospital for Special Surgery
    New York, New York, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

    • Session Coordinator(s)

  • JT

    Jeremy Tilstra, MD, PhD

    University of Pittsburgh
    Pittsburgh, Pennsylvania, United States

    Disclosure(s): Souffle theraputics: Consultant (Ongoing)

T cell antigen discovery remains a challenge in autoimmunity. This session explores two innovative methods which have the potential to map autoreactive T cell antigens. We will discuss their application in rheumatic diseases, uncovering novel antigens and advancing targeted immunotherapies.

Learning Objectives:

  • Compare and contrast two systems by which T cell antigen discovery can be performed
  • Explain how knowing T cell antigens will allow us to create tools to better understand autoimmune disease
  • Give examples of methods by which T cell antigen discovery can be used therapeutically to treat autoimmunity

Presentations:

  • 9:00 AM – 9:30 AM Central Time
    TBD

    Speaker: Mohammad Haj Dezfulian, PhD – University of Pennsylvania

  • 9:30 AM – 10:00 AM Central Time
    TBD

    Speaker: Alok Joglekar, PhD – University of Pittsburgh